Rocket Lab Shares Plunge 8.5% to $70.39 on 8% Volume Surge

RKLBRKLB

Shares of Rocket Lab fell 8.5% on Friday to a midday low of $70.39, trading 22.79 million shares (8% above average) after closing at $77.18. Rocket Lab beat Q3 EPS estimates by $0.02 with ($0.03) EPS on $155.1M revenue, up 48% year-over-year.

1. Shares Retreat with Elevated Volume

Rocket Lab shares declined 8.5% during mid-day trading on Friday, reflecting investor profit-taking following recent gains. Approximately 22.8 million shares changed hands, marking an 8% increase over its three-month daily average of 21.1 million. The pronounced sell-off occurred despite broadly stable market conditions, underscoring heightened sensitivity to near-term catalysts in the small-satellite launch sector.

2. Mixed Analyst Sentiment

Market observers remain divided, with 15 research firms rating the company a Buy or Strong Buy and six assigning a Hold or Sell opinion. The consensus consensus from seven Buy, five Hold and one Sell reports translates into a Moderate Buy outlook. Over the past two months, two firms upgraded to Strong Buy or Outperform stances, while one major Wall Street house pared back to Equal Weight. This dispersion in views highlights debate on the sustainability of revenue growth and margin improvement at Electron launch services.

3. Q3 Performance Exceeds Estimates

In its latest quarterly report, Rocket Lab posted adjusted loss per share of $0.03, beating the analyst consensus by $0.02. Revenue rose 48% year-over-year to $155.1 million, topping expectations by $2.6 million. The company reported a negative net margin of 35.6% and a negative return on equity of 27.3%, reflecting continued investment in research, development and infrastructure. Notably, revenue growth was driven by a record number of Electron launches and the initial deployments of Photon spacecraft.

4. Insider Dispositions and Institutional Moves

Senior vice president Arjun Kampani and director Frank Klein each executed stock sales, reducing their stakes by 2.3% and 0.4%, respectively, in late November. Over the trailing 90 days, insiders have collectively sold 2.73 million shares, representing 11.9% of outstanding stock. On the institutional front, Russell Investments expanded its position more than forty-fold in Q1, while Raymond James and Vident Advisory boosted stakes by 167% and 190%, respectively. Overall, institutional investors now control 71.8% of float, signaling strong confidence from large asset managers despite recent insider liquidity events.

Sources

FD